New combo therapy shows promise for Treatment-Linked blood cancer
Disease control
Ongoing
This study tests whether combining two drugs, venetoclax and azacitidine, can help people with a type of blood cancer called therapy-related myelodysplastic syndrome (t-MDS), which develops after prior cancer treatment. About 33 adults with intermediate to very high risk t-MDS wi…
Phase: PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated May 15, 2026 11:57 UTC